Immunohistochemical Expression of Epidermal Growth Factor Receptor among Metastatic and Nonmetastatic Oral Squamous Cell Carcinomas

JOURNAL TITLE: World Journal of Dentistry

1. Kumaresan Indrapriyadharshini
2. Ravi Saranyan
3. Balakrishnan Sekar
4. Ambika Murugesan
5. Ramdas M Nirmal
6. Thuckanickenpalayam R Yoithapprabhunath
Publishing Year
Author Affiliations
1. com.mps.common.model.Contributor@497e8ffd ,
2. com.mps.common.model.Contributor@283cf6e9 ,
3. com.mps.common.model.Contributor@6aeb3efa ,
4. com.mps.common.model.Contributor@43c2baba ,
5. com.mps.common.model.Contributor@7e7ec458 ,
6. com.mps.common.model.Contributor@31bafec0
Article keywords
Biomarker, Epidermal growth factor receptor, Immunohistochemistry, Metastasis, Oral squamous cell carcinoma


Aim: To evaluate and correlate the epidermal growth factor receptor (EGFR) expression in oral squamous cell carcinomas (OSCC) patients with metastasis and without metastasis. Materials and methods: The study comprised of 40 samples, 20 cases of metastatic and 20 nonmetastatic OSCC. All the cases were immunostained for EGFR antibody. Epidermal growth factor receptor stained sections were evaluated for staining intensity and distribution. The differences between the groups were statistically analyzed using Chi-square test. Results: Immunoexpression of EGFR in OSCC was 100% among the study groups, where metastatic group showed an increased positive expression comparing to nonmetastatic OSCC that show statistically significance among the study groups. Conclusion: Expression of EGFR can be used as reliable biomarker for prognosis which can be employed in the prediction of the survival of the patient with OSCC. Clinical significance: Since we are in the theragnostic era, evaluating and quantifying the expression of EGFR in OSCC patient will definitely pave a way in targeted drug therapy and personalized medicine for the diseased.

© 2019 Jaypee Brothers Medical Publishers (P) LTD.   |   All Rights Reserved

Powered by MPS ScholarStor